NIH Issues Notice of Default to BioNTech Over Alleged Royalty Payments
The National Institutes of Health (NIH) has taken legal action against BioNTech (NASDAQ: BNTX) for alleged failure to fulfill royalty
Read more
BioNTech
New COVID Variant Sweeps China, Is North America Next?
Remarkably, the world could be facing another bout with COVID this year, and with negative COVID test requirements having been
Read more
Pfizer-BioNTech Set To Supply The US Government With 105 Million COVID-19 Vaccine For US$3.2 Billion
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced on Wednesday a new vaccine supply agreement with the US
Read more
BioNTech Sees Vaccine Sales Push Q1 Revenues To €6.4 Billion
While many may view the pandemic as being over, the financial results of BioNTech (NASDAQ: BNTX) continue to say otherwise.
Read more
BioNTech Ends Q3 2021 With €6.1 Billion In Revenue
BioNTech SE (Nasdaq: BNTX) reported today its financial results for Q3 2021, highlighting quarterly revenue of €6.1 billion. This figure
Read more
BioNTech Sent Plummeting Following Damning Whistleblower Report, News of Covid-19 Pills
Shares of BioNTech (NASDAQ: BNTX) were sent into a nosedive on Friday, after a whistleblower report made scathing revelations surrounding
Read more
Pfizer-BioNTech COVID-19 Vaccine Trial For Ages 5-11 Returns Favorable Topline Results
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced this morning the topline results coming from its phase 2/3
Read more